Uses, Methods, Polypeptides and Polynucleotides
The present invention relates to polypeptides comprising bacteriophage polypeptides for use in preventing or treating autoimmune diseases, for example type 1 diabetes. Polypeptides comprising fragments or variants of bacteriophage polypeptides may also be used for this purpose. Nucleic acid molecule...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English Estonian |
Published |
15.08.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to polypeptides comprising bacteriophage polypeptides for use in preventing or treating autoimmune diseases, for example type 1 diabetes. Polypeptides comprising fragments or variants of bacteriophage polypeptides may also be used for this purpose. Nucleic acid molecules encoding such polypeptides may also be used for this purpose. The present invention also relates to vaccine compositions comprising such a polypeptide or comprising a nucleic acid molecule encoding such a polypeptide. Certain isolated peptides comprising fragments of bacteriophage polypeptides also form part of the present invention. The present invention also relates to methods of screening for an autoimmune disease by determining the level, in a body fluid sample obtained from a subject, of an antibody that binds to a bacteriophage polypeptide or fragment or variant thereof.
Leiutis käsitleb polüpeptiide, mis sisaldavad bakteriofaagi polüpeptiide, kasutamiseks autoimmuunhaiguse, nagu 1. tüüpi diabeedi, ennetamiseks või ravimiseks. Selleks otstarbeks võidakse kasutada ka polüpeptiide, mis sisaldavad bakteriofaagi polüpeptiidide fragmente või variante. Selleks otstarbeks võidakse kasutada ka nukleiinhappemolekule, mis kodeerivad selliseid polüpeptiide. Leiutis käsitleb ka vaktsiinikompositsioone, mis sisaldavad sellist polüpeptiidi või mis sisaldavad nukleiinhappemolekuli, mis kodeerib sellist polüpeptiidi. Leiutisega on hõlmatud ka teatud isoleeritud peptiidid, mis sisaldavad bakteriofaagi polüpeptiidide fragmente. Leiutis käsitleb ka autoimmuunhaiguse skriinimismeetodeid, määrates subjektilt saadud kehavedelikuproovis bakteriofaagi polüpeptiidi või selle fragmendi või variandiga seonduva antikeha taset. |
---|---|
Bibliography: | Application Number: EE2024P000030 |